Alpha-GPC (L-Alpha glycerylphosphorylcholine / Choline alfoscerate) for Dementia
Alpha-GPC shows modest, consistent cognitive and behavioral benefits in dementia trials, mostly as an add-on to donepezil, but the evidence comes from small studies dominated by a single research group, so it remains preliminary rather than an established treatment. No regulator has approved it for dementia, and a possible stroke-risk signal warrants caution.
Why this grade7-layer evidence engine
This earns a Preliminary (B) grade because the human-trial data lean positive but are thin. A 2023 meta-analysis (PMID 36683513, n=861) found that adding alpha-GPC to donepezil improved cognition versus donepezil alone (MMSE +1.72; ADAS-Cog -5.76), and a 2003 double-blind RCT in mild-to-moderate Alzheimer's (PMID 12637119, n=261) showed the treated group improved on ADAS-Cog while placebo declined. The ASCOMALVA RCT (PMID 28035924, n=113) reported reduced behavioral and psychological symptoms when alpha-GPC was combined with donepezil.
The benefit is real but the body of evidence is fragile. Trials are small (roughly 100-300 patients), and the pivotal studies trace back largely to one Italian research group, raising researcher-allegiance concerns. A 2025 meta-analysis (PMID 41426989, n=358) found alpha-GPC edged out citicoline on a global rating scale but showed no advantage on memory or word fluency. There is no Cochrane review and no large independent multicenter trial to confirm durability.
Regulators and clinics do not endorse it for dementia. The US FDA's GRAS notice (FDA has no questions) speaks only to food-ingredient safety, not efficacy, and no cognitive or memory claim has been approved; Cleveland Clinic mentions alpha-GPC only as a well-absorbed choline source, not a dementia therapy. A drug-interaction flag and an observational stroke-risk signal add to the caution: alpha-GPC is a reasonable research-grade candidate, not a substitute for proven dementia drugs.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.625
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status